Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 17 hours ago
Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation: 17/09/2025, Revision: 2, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation...
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 21, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 24, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 30, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 39, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation...
Agenda - PDCO agenda of the 21-24 July 2026 meeting
about 17 hours ago
Agenda - PDCO agenda of the 21-24 July 2026 meeting
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 9, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation...
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 12, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation...
Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation: 23/02/2001, Revision: 25, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation...
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 17, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date...
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 6, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of...